Literature DB >> 25954441

A Comparison of Data Driven-based Measures of Adherence to Oral Hypoglycemic Agents in Medicaid Patients.

Vivienne J Zhu1, Wanzhu Tu1, Marc B Rosenman1, J Marc Overhage2.   

Abstract

We evaluated and compared different methods for measuring adherence to Oral Antihyperglycemic Agents (OHA), based on the correlation between these measures and glycated hemoglobin A1C (HbA1c) levels in Medicaid patients with Type 2 diabetes. An observational sample of 831 Medicaid patients with Type 2 diabetes who had HbA1c test results recorded between January 1, 2001 and December 31, 2005 was identified in the Indiana Network of Patient Care (INPC). OHA adherence was measured by medication possession ratio (MPR), proportion of days covered (PDC), and the number of gaps (GAP) for 3, 6, and 12-month intervals prior to the HbA1c test date. All three OHA adherence measurements showed consistent and significant correlation with HbA1c level. The 6-month PDC showed the strongest association with HbA1c levels in both unadjusted (-1.07, P<0.0001) and adjusted (-1.12, P<0.0001) models.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25954441      PMCID: PMC4420014     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  26 in total

Review 1.  Prevalence and economic consequences of medication adherence in diabetes: a systematic literature review.

Authors:  Won Chan Lee; Sanjeev Balu; David Cobden; Ashish V Joshi; Chris L Pashos
Journal:  Manag Care Interface       Date:  2006-07

2.  Measurements of medication adherence in diabetic patients with poorly controlled HbA(1c).

Authors:  H W Cohen; C Shmukler; R Ullman; C M Rivera; E A Walker
Journal:  Diabet Med       Date:  2010-02       Impact factor: 4.359

3.  Racial differences in glycemic markers: a cross-sectional analysis of community-based data.

Authors:  Elizabeth Selvin; Michael W Steffes; Christie M Ballantyne; Ron C Hoogeveen; Josef Coresh; Frederick L Brancati
Journal:  Ann Intern Med       Date:  2011-03-01       Impact factor: 25.391

Review 4.  Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus.

Authors:  Richard R Rubin
Journal:  Am J Med       Date:  2005-05       Impact factor: 4.965

5.  Medication adherence and associated hemoglobin A1c in type 2 diabetes.

Authors:  Kimberley Krapek; Kathleen King; Susan S Warren; Karen G George; Dorothy A Caputo; Karen Mihelich; Elizabeth M Holst; Michael B Nichol; Sheng G Shi; Kevin B Livengood; Steve Walden; Teresa J Lubowski
Journal:  Ann Pharmacother       Date:  2004-07-06       Impact factor: 3.154

6.  Comparison of methods to assess medication adherence and classify nonadherence.

Authors:  Richard A Hansen; Mimi M Kim; Liping Song; Wanzhu Tu; Jingwei Wu; Michael D Murray
Journal:  Ann Pharmacother       Date:  2009-03-03       Impact factor: 3.154

7.  Physician performance and racial disparities in diabetes mellitus care.

Authors:  Thomas D Sequist; Garrett M Fitzmaurice; Richard Marshall; Shimon Shaykevich; Dana Gelb Safran; John Z Ayanian
Journal:  Arch Intern Med       Date:  2008-06-09

8.  Oral antidiabetic medication adherence and glycemic control in managed care.

Authors:  Yelena Rozenfeld; Jacquelyn S Hunt; Craig Plauschinat; Ken S Wong
Journal:  Am J Manag Care       Date:  2008-02       Impact factor: 2.229

Review 9.  Medication adherence: its importance in cardiovascular outcomes.

Authors:  P Michael Ho; Chris L Bryson; John S Rumsfeld
Journal:  Circulation       Date:  2009-06-16       Impact factor: 29.690

Review 10.  Medication taking and diabetes: a systematic review of the literature.

Authors:  Peggy Soule Odegard; Kam Capoccia
Journal:  Diabetes Educ       Date:  2007 Nov-Dec       Impact factor: 2.140

View more
  4 in total

1.  Accurate Medication Adherence Measurement Using Administrative Data for Frequently Hospitalized Patients.

Authors:  Rafia S Rasu; Suzanne L Hunt; Junqiang Dai; Huizhong Cui; Milind A Phadnis; Nishank Jain
Journal:  Hosp Pharm       Date:  2020-06-02

2.  The impact of depression medications on oral antidiabetic drug adherence in patients with diabetes and depression.

Authors:  Shan Xing; Gregory S Calip; Alex D Leow; Shiyun Kim; Glen T Schumock; Daniel R Touchette; Todd A Lee
Journal:  J Diabetes Complications       Date:  2017-12-27       Impact factor: 2.852

3.  Racial and Geographic Disparities in Endocrine Therapy Adherence Among Younger Breast Cancer Survivors.

Authors:  Sue P Heiney; Samantha Truman; Oluwole A Babatunde; Tisha M Felder; Jan M Eberth; Elizabeth Crouch; Karen E Wickersham; Swann Arp Adams
Journal:  Am J Clin Oncol       Date:  2020-07       Impact factor: 2.787

4.  Impact of adherence goal awareness intervention on PDC in various settings: Does awareness help modify medication-taking behavior?

Authors:  A R Mercadante; S Lee; K Uh; A Chau; U Truong; A Jeong; M Hata; A V Law
Journal:  Explor Res Clin Soc Pharm       Date:  2021-09-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.